Eversheds advises CBPE Capital on £225 million sale
Eversheds has advised CBPE Capital LLP, the mid-market private equity firm, on the sale of IDIS Group Holdings to Clinigen Group plc.
CBPE Capital LLP (CBPE), has sold IDIS Group Holdings (IDIS) to Clinigen Group plc (Clinigen), the AIM listed speciality pharmaceuticals and pharmaceuticals services business, for an Enterprise Value of £225m.
The transaction represents a money multiple of 22x CBPE’s £9.4m investment in Idis.